🇺🇸
United States · US · US:0002-1436_36fde2df-4f86-4823-a2d5-832041e22960
EMGALITY
UNIISPLATC N02CD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerEli Lilly and Company
CountryUS (United States)
ATC codeN02CD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1100021436111 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01)
- ndc1100021436612 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE
Annotations
UNII (FDA Substance ID)
55KHL3P693
GALCANEZUMAB
RxCUI 2058846
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "55KHL3P693",
"rxcui": "2058846",
"inchikey": null,
"display_name": "GALCANEZUMAB",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"33a147be-233a-40e8-a55e-e40936e28db0": {
"match": "brand_token",
"title": "EMGALITY (GALCANEZUMAB-GNLM) INJECTION, SOLUTION [ELI LILLY AND COMPANY]",
"spl_version": "15",
"published_date": "2025-11-26"
}
},
"productid": "0002-1436_36fde2df-4f86-4823-a2d5-832041e22960",
"productndc": "0002-1436",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GALCANEZUMAB",
"proprietary_name": "EMGALITY",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761063",
"marketing_category": "BLA",
"nonproprietary_name": "galcanezumab-gnlm",
"start_marketing_date": "20180927",
"active_numerator_strength": "120"
}Related drugs
Other records sharing ATC code N02CD02.
Access this data programmatically
Query EMGALITY and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.